Parliament of Canada
Skip to search results

Bills All Sessions January 17, 1994, to present

Refine your search

Search results for patent act

Results 1-26 of 26 for patent act

C-275

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (infringement of a <mark class='highlight'>patent</mark>)

C-251

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (<mark class='highlight'>patented</mark> medicines)

C-275

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (infringement of a <mark class='highlight'>patent</mark>)

C-454

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (<mark class='highlight'>patented</mark> medicines)

C-251

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (<mark class='highlight'>patented</mark> medicines)

C-311

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark>

S-17

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark>

C-29

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark>

C-460

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark>

C-361

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (life of <mark class='highlight'>patents</mark> pertaining to medicine)

C-248

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark>

C-274

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark>

C-349

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark>

C-349

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark>

C-56

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> and the Food and Drugs <mark class='highlight'>Act</mark>

C-284

An <mark class='highlight'>Act</mark> to ensure the necessary supply of <mark class='highlight'>patented</mark> drugs to deal with domestic emergencies

C-363

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (investigations regarding the making of medicines available at no charge to the seriously ill)

C-398

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (drugs for international humanitarian purposes)

S-208

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> and the Food and Drugs <mark class='highlight'>Act</mark> (drugs for international humanitarian purposes)

C-393

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (drugs for international humanitarian purposes) and to make a consequential amendment to another <mark class='highlight'>Act</mark>

C-261

An <mark class='highlight'>Act</mark> to ensure the necessary supply of <mark class='highlight'>patented</mark> drugs in cases of domestic emergency or to deal with crises in countries that receive assistance from Canada

C-9

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> and the Food and Drugs <mark class='highlight'>Act</mark> (The Jean Chrétien Pledge to Africa)

S-232

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (drugs for international humanitarian purposes) and to make a consequential amendment to another <mark class='highlight'>Act</mark>

C-473

An <mark class='highlight'>Act</mark> to ensure the necessary supply of <mark class='highlight'>patented</mark> drugs in cases of domestic emergency or to deal with crises in countries that receive assistance from Canada

C-393

An <mark class='highlight'>Act</mark> to amend the <mark class='highlight'>Patent</mark> <mark class='highlight'>Act</mark> (drugs for international humanitarian purposes) and to make a consequential amendment to another <mark class='highlight'>Act</mark>

C-261

An <mark class='highlight'>Act</mark> to ensure the necessary supply of <mark class='highlight'>patented</mark> drugs in cases of domestic emergency or to deal with crises in countries that receive assistance from Canada
Historical information

C-275

An Act to amend the Patent Act (infringement of a patent)
Bill type
Private Member’s Bill
Sponsor
Brian Masse
Current status
Outside the Order of Precedence
Latest activity
Introduction and first reading on January 29, 2009 (House of Commons)
Historical information

C-251

An Act to amend the Patent Act (patented medicines)
Bill type
Private Member’s Bill
Sponsor
Hon. Dan McTeague
Current status
Outside the Order of Precedence
Latest activity
Introduction and first reading on October 24, 2002 (House of Commons)
Historical information

C-275

An Act to amend the Patent Act (infringement of a patent)
Bill type
Private Member’s Bill
Sponsor
Brian Masse
Current status
Outside the Order of Precedence
Latest activity
Reinstated from previous session on March 3, 2010 (House of Commons)
Historical information

C-454

An Act to amend the Patent Act (patented medicines)
Bill type
Private Member’s Bill
Sponsor
Hon. Dan McTeague
Current status
Outside the Order of Precedence
Latest activity
Introduction and first reading on May 1, 2002 (House of Commons)
Historical information

C-251

An Act to amend the Patent Act (patented medicines)
Bill type
Private Member’s Bill
Sponsor
Hon. Dan McTeague
Current status
Outside the Order of Precedence
Latest activity
Reinstated from previous session on February 2, 2004 (House of Commons)
Historical information

C-311

An Act to amend the Patent Act
Bill type
Private Member’s Bill
Sponsor
John Solomon
Current status
Referred to committee before second reading in the House of Commons
Historical information

S-17

An Act to amend the Patent Act
Bill type
Senate Government Bill
Sponsor
Sen. Sharon Carstairs
Current status
Royal assent received
Latest activity
Royal assent on June 14, 2001 (Senate)
Historical information

C-29

An Act to amend the Patent Act
Bill type
House Government Bill
Sponsor
Hon. David Emerson
Current status
Royal assent received
Latest activity
Royal assent on May 5, 2005 (Senate)
Historical information

C-460

An Act to amend the Patent Act
Bill type
Private Member’s Bill
Sponsor
Judy Wasylycia-Leis
Current status
Outside the Order of Precedence
Latest activity
Introduction and first reading on May 2, 2002 (House of Commons)
Historical information

C-361

An Act to amend the Patent Act (life of patents pertaining to medicine)
Bill type
Private Member’s Bill
Sponsor
Jim Gouk
Current status
Outside the Order of Precedence
Historical information

C-248

An Act to amend the Patent Act
Bill type
Private Member’s Bill
Sponsor
John Solomon
Current status
Referred to committee before second reading in the House of Commons
Historical information

C-274

An Act to amend the Patent Act
Bill type
Private Member’s Bill
Sponsor
Brian Masse
Current status
Bill defeated
Latest activity
Bill defeated at second reading on May 4, 2005 (House of Commons)
Historical information

C-349

An Act to amend the Patent Act
Bill type
Private Member’s Bill
Sponsor
Brian Masse
Current status
Outside the Order of Precedence
Latest activity
Introduction and first reading on June 22, 2006 (House of Commons)
Historical information

C-349

An Act to amend the Patent Act
Bill type
Private Member’s Bill
Sponsor
Brian Masse
Current status
Outside the Order of Precedence
Latest activity
Reinstated from previous session on October 16, 2007 (House of Commons)
Historical information

C-56

An Act to amend the Patent Act and the Food and Drugs Act
Bill type
House Government Bill
Sponsor
Right Hon. Jean Chrétien
Current status
At consideration in committee in the House of Commons
Latest activity
Second reading and referral to committee on November 7, 2003 (House of Commons)
Historical information

C-284

An Act to ensure the necessary supply of patented drugs to deal with domestic emergencies

Short title: Drug Supply Act

Bill type
Private Member’s Bill
Sponsor
Peter Stoffer
Current status
Outside the Order of Precedence
Latest activity
Introduction and first reading on November 15, 2004 (House of Commons)
Historical information

C-363

An Act to amend the Patent Act (investigations regarding the making of medicines available at no charge to the seriously ill)
Bill type
Private Member’s Bill
Current status
Outside the Order of Precedence
Historical information

C-398

An Act to amend the Patent Act (drugs for international humanitarian purposes)
Bill type
Private Member’s Bill
Sponsor
Hélène Laverdière
Current status
Bill defeated
Latest activity
Bill defeated at second reading on November 28, 2012 (House of Commons)
Historical information

S-208

An Act to amend the Patent Act and the Food and Drugs Act (drugs for international humanitarian purposes)
Bill type
Senate Public Bill
Sponsor
Sen. Mobina S.B. Jaffer
Current status
Bill not proceeded with
Latest activity
Dropped from the Senate Order Paper on March 29, 2012 (Senate)
Historical information

C-393

An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act
Bill type
Private Member’s Bill
Sponsor
Paul Dewar
Current status
At second reading in the Senate
Latest activity
Debate at second reading on March 24, 2011 (Senate)
Historical information

C-261

An Act to ensure the necessary supply of patented drugs in cases of domestic emergency or to deal with crises in countries that receive assistance from Canada

Short title: Drug Supply Act

Bill type
Private Member’s Bill
Sponsor
Hon. Lorne Nystrom
Current status
Outside the Order of Precedence
Latest activity
Reinstated from previous session on February 2, 2004 (House of Commons)
Historical information

C-9

An Act to amend the Patent Act and the Food and Drugs Act (The Jean Chrétien Pledge to Africa)
Bill type
House Government Bill
Sponsor
Hon. Lucienne Robillard
Current status
Royal assent received
Latest activity
Royal assent on May 14, 2004 (Senate)
Historical information

S-232

An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act
Bill type
Senate Public Bill
Sponsor
Sen. Yoine Goldstein
Current status
At consideration in committee in the Senate
Latest activity
Referral to committee on June 16, 2009 (Senate)
Historical information

C-473

An Act to ensure the necessary supply of patented drugs in cases of domestic emergency or to deal with crises in countries that receive assistance from Canada

Short title: Drug Supply Act

Bill type
Private Member’s Bill
Sponsor
Hon. Lorne Nystrom
Current status
Outside the Order of Precedence
Latest activity
Introduction and first reading on June 6, 2002 (House of Commons)
Historical information

C-393

An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act
Bill type
Private Member’s Bill
Sponsor
Judy Wasylycia-Leis
Current status
At consideration in committee in the House of Commons
Latest activity
Second reading and referral to committee on December 2, 2009 (House of Commons)
Historical information

C-261

An Act to ensure the necessary supply of patented drugs in cases of domestic emergency or to deal with crises in countries that receive assistance from Canada

Short title: Drug Supply Act

Bill type
Private Member’s Bill
Sponsor
Hon. Lorne Nystrom
Current status
Outside the Order of Precedence
Latest activity
Introduction and first reading on October 28, 2002 (House of Commons)
Export as: JSON XML RSS

For more data options, please see Open Data

Top of page